<DOC>
	<DOCNO>NCT01382849</DOCNO>
	<brief_summary>Florbetapir F 18 experimental radioactive drug may allow doctor image change brain use PET ( Positron Emission Tomography ) scanner . The purpose study evaluate image characteristic , Florbetapir F 18 ( also know 18F-AV-45 ) patient previously undergone bleeding brain . Florbetapir F 18 bind amyloid-ß peptide ( Aß ) accumulate brain patient bleed . These accumulation call amyloid plaque extensive label cerebral amyloid angiopathy ( CAA ) . Florbetapir F 18 stick amyloid plaque brain emits low level gamma ray detect PET camera . MRI detect microbleeds identify marker clinically silent hemorrhage bleeding-prone vessel . Another image marker vessel damage risk bleed spot sign ( SS ) . Finally , certain genetic signature ( ApoE genotype ) show associated Aß deposition brain predispose patient higher risk bleed . This research study explore interaction factor understand physiology intracerebral bleeding .</brief_summary>
	<brief_title>F-18-AV-45 Uptake , Spot Sign Presence Cerebral Amyloid Angiopathy ( CAA ) Primary Intracranial Hemorrhage ( ICH )</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Amyloidosis</mesh_term>
	<mesh_term>Intracranial Hemorrhages</mesh_term>
	<mesh_term>Cerebral Amyloid Angiopathy</mesh_term>
	<mesh_term>Cerebral Amyloid Angiopathy , Familial</mesh_term>
	<criteria>Prior intracranial hemorrhage least 3 month prior Patients &gt; 18 year 1 . Modified Rankin score &gt; 3 . 2 . Clinically significant medical comorbidities opinion investigator might pose potential safety risk subject . 3 . Women childbearing potential surgically sterile , refrain sexual activity use reliable method contraception . 4 . Have history relevant severe drug allergy hypersensitivity 5 . Patients withdraw consent . Age gendermatched microbleed patient previously demonstrate MRI microbleeds without prior macrobleeds recruit stroke clinic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>amyloid</keyword>
	<keyword>cerebral amyloid angiopathy</keyword>
	<keyword>hemorrhage</keyword>
	<keyword>cerebral spot sign</keyword>
</DOC>